Le Lézard
Classified in: Health, Business
Subjects: LEG, AVO

American College of Surgeons opposes the "Stop Surprise Medical Bills" legislation introduced by Senator Cassidy and the bipartisan Senate working group


WASHINGTON, May 16, 2019 /PRNewswire/ -- Today, the American College of Surgeons (ACS) announced its opposition to the legislation introduced by Senator Bill Cassidy (R-LA) titled "Stop Surprise Medical Bills."  Unfortunately, the legislation is written in a manner that provides unbalanced power to the health insurance industry.

In setting payment rates for out-of-network physicians, the legislation uses insurer-dictated median in-network rates as the amount the plan pays the physician.  This approach will likely have two major consequences:

While the American College of Surgeons supports an arbitration process, this legislation allows the health plans to include the costs of arbitration as part of "medical care costs" in their medical loss ratio.  This legislation once again gives the health plans a generous gift as they work to manipulate health care costs to their advantage.

Further, the bill allows the arbitrator to use insurance-controlled data rather than an independent database for benchmarking purposes.  The ACS believes that an independent database, such as FAIR Health, which is used successfully in New York, is essential to maintaining the integrity of the arbitration process. 

The American College of Surgeons is committed to working with Congress to develop legislation that would address the important issue of surprise medical billing.  Such a solution should strike a balance between hospitals, insurers and physicians, while keeping patients out of the middle.  The ACS believes that this legislation needs to be developed in a holistic manner, whereby all the root causes of this problem are appropriately addressed.  Unfortunately, the proposal released today does not accomplish this goal.   

About the American College of Surgeons
The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and improve the quality of care for surgical patients. The College is dedicated to the ethical and competent practice of surgery.  Its achievements have significantly influenced the course of scientific surgery in America and have established it as an important advocate for all surgical patients. The College has more than 82,000 members and is the largest organization of surgeons in the world.  For more information, visit www.facs.org.

 

SOURCE American College of Surgeons


These press releases may also interest you

at 08:44
Understanding the underlying mechanisms of normal and pathological cellular processes is essential for developing new drugs. Fortunately, modern techniques and experimental methods have greatly accelerated progress. The latest issue of JPA features...

at 08:42
It's no secret that if a person is healthy, they can do more than just survive. A healthy individual can have more life experiences, engage in more activities, and enjoy a more fulfilling quality of life. This larger goal of a healthy life well lived...

at 08:41
Wound healing can be a long and complicated process. Along with the healing itself, patients must consider factors such as a clean environment and consistent care. Quality of life can also be impacted by something as simple as unpleasant smells...

at 08:41
In a transformative approach to combating human trafficking in the United States, Safe House Project is revolutionizing the fight against this pervasive crime. By equipping hundreds of thousands of individuals across the nation with the tools to...

at 08:40
The "Global Cell Counting Market: Analysis By Product, By Application, By End-User, By Region Size, Trends and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The global cell counting market was valued at US$9.98...

at 08:40
Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the development and commercialization of innovative oncology drugs, announced today that their...



News published on and distributed by: